Ask AI
ProCE Banner Activity

Tardive Dyskinesia in People With Mood Disorders

Clinical Thought

Read this ClinicalThought for an expert view on the burden and prevalence of tardive dyskinesia in patients with mood disorders, including evaluation of risk factors in relation to patient age and best practices for screening and treatment with VMAT2 inhibitors.

Released: August 06, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Neurocrine Biosciences.

Neurocrine Biosciences

Disclosure

Primary Author

Stanley N. Caroff, MD: consultant/advisor/speaker: Medicure.